Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $50.73 million. The enterprise value is $61.34 million.

Market Cap	50.73M
Enterprise Value	61.34M

Important Dates

The next estimated earnings date is Wednesday, August 12, 2026, before market open.

Earnings Date	Aug 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.78 million shares outstanding. The number of shares has increased by 3.27% in one year.

Current Share Class	6.78M
Shares Outstanding	6.78M
Shares Change (YoY)	+3.27%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.02%
Owned by Institutions (%)	18.13%
Float	3.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.46
P/TBV Ratio	0.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 39.87, with a Debt / Equity ratio of 0.77.

Current Ratio	39.87
Quick Ratio	15.79
Debt / Equity	0.77
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.07

Financial Efficiency

Return on equity (ROE) is -37.07% and return on invested capital (ROIC) is -13.00%.

Return on Equity (ROE)	-37.07%
Return on Assets (ROA)	-12.69%
Return on Invested Capital (ROIC)	-13.00%
Return on Capital Employed (ROCE)	-22.71%
Weighted Average Cost of Capital (WACC)	9.16%
Revenue Per Employee	n/a
Profits Per Employee	-$2.79M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.39% in the last 52 weeks. The beta is 1.91, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	1.91
52-Week Price Change	-72.39%
50-Day Moving Average	8.02
200-Day Moving Average	11.17
Relative Strength Index (RSI)	28.89
Average Volume (20 Days)	17,649

Short Selling Information

The latest short interest is 233,731, so 3.45% of the outstanding shares have been sold short.

Short Interest	233,731
Short Previous Month	232,840
Short % of Shares Out	3.45%
Short % of Float	6.45%
Short Ratio (days to cover)	9.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-44.45M
Pretax Income	-47.38M
Net Income	-47.38M
EBITDA	-44.40M
EBIT	-44.45M
Earnings Per Share (EPS)	-$7.04

Full Income Statement

Balance Sheet

The company has $74.57 million in cash and $85.19 million in debt, giving a net cash position of -$10.61 million or -$1.57 per share.

Cash & Cash Equivalents	74.57M
Total Debt	85.19M
Net Cash	-10.61M
Net Cash Per Share	-$1.57
Equity (Book Value)	110.70M
Book Value Per Share	16.32
Working Capital	183.58M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-33.76M
Capital Expenditures	n/a
Depreciation & Amortization	48,000
Net Borrowing	n/a
Free Cash Flow	-33.76M
FCF Per Share	-$4.98

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.27%
Shareholder Yield	-3.27%
Earnings Yield	-93.39%
FCF Yield	-66.55%

Analyst Forecast

The average price target for Instil Bio is $7.00, which is -6.42% lower than the current price. The consensus rating is "Hold".

Price Target	$7.00
Price Target Difference	-6.42%
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2